BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 73563)

  • 1. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM; Laake K
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract]   [Full Text] [Related]  

  • 5. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human plasma kinin system. II. Contact activation of plasma prekallikrein and factor XI in factor XII-deficiency plasma.
    Ozge-Anwar AH; Movat HZ; Scott JG
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):330-7. PubMed ID: 4108176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H; Miyata T; Iwanaga S; Yamamoto T
    Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.